Lexaria Bioscience Corp. (NASDAQ:LEXXW) Short Interest Up 55.6% in May

Lexaria Bioscience Corp. (NASDAQ:LEXXW) was the recipient of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 4,200 shares, a growth of 55.6% from the May 15th total of 2,700 shares. Based on an average daily trading volume, of 4,300 shares, the short-interest ratio is currently 1.0 days.

Lexaria Bioscience Price Performance

Shares of NASDAQ LEXXW traded down $0.01 during midday trading on Monday, reaching $0.22. 1,810 shares of the company traded hands, compared to its average volume of 10,520. The stock has a 50-day moving average price of $0.25 and a 200 day moving average price of $0.40. Lexaria Bioscience has a 52 week low of $0.15 and a 52 week high of $2.00.

Lexaria Bioscience Company Profile

Lexaria Bioscience Corp. operates as a biotechnology company. It develops and out-licenses its patented drug delivery technology, DehydraTECH, which combines lipophilic molecules or active pharmaceutical ingredients with specific long-chain fatty acids and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing while promoting healthier oral ingestion methods.